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Abstract
The emergence of multidrug-resistance Mycobacterium tuberculosis is an increasing threat to tuberculosis control programmes. Suscepti-
bility testing of Mycobacterium tuberculosis complex isolates by traditional methods requires a minimum of 14 days. This can be reduced
signiﬁcantly if molecular analysis is used. DNA sequencing is a good method for detecting mutation, but cannot be used routinely
because of its relatively high cost. A sensitive and speciﬁc microarray has been designed to detect mutations in the rifampin resistance
determining region of rpoB and loci in katG and inhA associated with isoniazid (INH) resistance. A panel of Mycobacterium tuberculosis iso-
lates containing 13 different rpoB genotypes, two mutation genotypes within codon 315 of katG and one mutation genotypes at inhA
was used to validate the microarray. The results obtained indicate that 100% of rifampicin-resistant M. tuberculosis strains isolated in
Chongqing had rpoB mutations, with 531-Ser and 526-His being the most common positions substituted. Of the total 50 INH resistant
isolates, 82% had a katG315 mutation and 18% had an inhA mutation. All the mutations detected by the microarray method were also
conﬁrmed by conventional DNA sequencing. It is demonstrated that the microarray is an efﬁcient, specialized technique and can be
used as a rapid method for detecting rifampin and isoniazid resistance.
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Introduction
China, a country with the highest number of tuberculosis
cases reported worldwide and the highest number of multi-
drug-resistance Mycobacterium tuberculosis (MDR-TB) patients,
was regarded by the World Health Organization as a major
hot-spot region for M. tuberculosis infection [1]. A suitably-
equipped laboratory allowing the timely and adequate diagno-
sis of TB and reliable susceptibility testing of TB isolates is
lacking throughout most regions of China [2]. MDR-TB, which
were deﬁned as being resistant to at least isoniazid (INH) or
rifampin (RIF), are emerging and could maintain their virulence
[3]. INH-resistant strains most commonly carry mutations in
either the gene (katG) encoding catalase-peroxidase, which is
required for the activation of prodrug INH, or in the pro-
moter region of the inhA, encoding enoyl acyl reductase, which
is involved in mycobacterium biosynthesis [4,5]. Mutations in
several other genes may also lead to INH resistance but are
less common [5,6]. RIF resistance strains serve as a surrogate
marker for MDR-TB detection because 96% RIF-resistant
strains are also resistant to INH and the frequency of collect-
ing mutations against RIF is 10)8 compared to 10)6 for INH
[7]. Resistance in RIF has been attributed to mutations within
an 81-bp RIF resistance-determining region (RRDR) of the
rpoB gene, corresponding to codons 509–533 in 96% of RIF-
resistance strains [8,9]. Mutations outside of RRDR have also
been reported, with a frequency of <2% [10].
Conventional culture-based bacterial identiﬁcation systems
can provide deﬁnitive results, but are labour intense and
time-consuming, usually requiring at least 14 days from pri-
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mary isolation to produce [11]. Recently, oligonucleotide
arrays, comprising a new microarray technique, have been
described for mutation detection. DNA microarrays, which
have various applications in microbiology [12,13], could be
applied to analyze multiple loci in parallel and have been
reported with respect to the analysis of rpoB mutations that
lead to RIF resistance, or katG and inhA mutations that lead
to INH resistance [14].
For such reasons, we developed a specialized oligonucleo-
tide microarray coupled with PCR for the identiﬁcation of
TB and the detection of rpoB, katG and inhA mutations. The
PCR-ampliﬁed products were hybridized to an oligonucleo-
tide microarray consisting of probes that could detect variant
mutants of the rpoB, katG and inhA gene mutations. In the
present study, we evaluated the clinical efﬁcacy of the DNA
microarray technology and compared this method with DNA
sequencing for the detection of rifampin-resistant and isonia-
zid-resistant TB strains from a clinical sample. This is the ﬁrst
report to describe microarray analysis of mutations in the
rpoB, katG and inhA genes of M. tuberculosis in a large number
of clinical isolates in Chongqing.
Materials and Methods
Selection of clinical specimens and control samples
Seventy clinical isolates of M. tuberculosis from patients were
obtained from Southwest Hospital in Chongqing. All cultures
were then transferred on Lowenstein–Jensen agar slants and
grown at 37C for 2 weeks. Their antimicrobial susceptibility
patterns were determined using the BACTEC 460 system
(Becton-Dickinson, Sparks, MD, USA).
Design and construction of the oligonucleotide microarray
The unique and conserved regions of oligonucleotides for
hybridization analysis were designed using ARRAY DESIGNER
software. The microarray was printed according to the spot-
ting pattern (Fig. 1). A set of 16 oligonucleotides probes for
identiﬁcation of RIF-resistant and INH-resistant M. tuberculo-
sis strains on microarray are shown in Table 1. The capture
probes were applied to the aldehyde-activated slides (Amino-
Slide; CapitalBio Corp., Beijing, China) at a concentration
of 10 lmol/L in 50% dimethyl sulphoxide and covalently
immobilized on the slides by the mediation of an amino
group at their ends. Additionally, a set of probes for control
purposes were also included.
Preparation of DNA extracts
The sputum sample was shaken at room temperature with
an equal volume of 1% acetylcysteine (Sigma, St Louis, MO,
USA) and 0.9% NaCl at 300 revolution/min for 30 min. DNA
from M. tuberculosis isolates was obtained by direct heat of
the suspended culture at 80C for 60 min in 1· TE (10 mM
Tris-HCl and 1 mM EDTA, pH 8.0) buffer. In brief, bacteria
were lysed by vortexing a single fresh colony suspended in
100 lL of 1· TE (10 mM Tris-HCl, 1 mM EDTA, pH 7.5)
with 50 mg of glass beads (Sigma).
(a)
(b)
FIG. 1. Schematic diagram of the microarray design. Probes were
spotted in quintuplicate. (a) The pattern of oligonucleotides of
the rpoB gene printed on the array surface. (b) The pattern of oligo-
nucleotides of the katG and inhA gene printed on the array surface.
QC, tetramethyl-6-carboxyrhodamine-labelled oligonucleotide used
for quality control of surface chemistry; IC, internal control probe
for PCR; EC, external control probe for hybridization-based quanti-
tation; BC, dimethyl sulphoxide control for the quality of microarray;
NC, negative control probe; WT, wild-type.
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Ampliﬁcation of rpoB, katG and inhA genes
The extracted bacteria DNA was boiled for 5 min and then
centrifuged to collect the supernatant as a crude template.
Each PCR contained 250 lM concentrations of each deoxy-
nucleoside triphosphate, 1 U of Taq DNA polymerase,
10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2 and
1 lL of lysate supernatant as a template source. For muta-
tion analysis of the RRDR, a 437-bp fragment of the rpoB
gene was ampliﬁed using primer rpoB-for1 5¢-TGGTCCG
CTTGCACGAGGGTCAGA-3¢ (nucleotides 2098–2120)
and rpoB-rev1 5¢-CTCAGGGGTTTCGATCGGGCACAT-3¢
(nucleotides 2534–2511), as described previously [9]. For
mutation analysis of the katG gene, the fragment of the katG
gene was ampliﬁed using primer katG-for1 5¢-AT
CTGGAGAACCCGCTGGC-3¢ (nucleotides 2622–2640) and
katG-rev1 5¢-ACCCATGTCTCGGTGGATCAG-3¢ (nucleo-
tides 3241–3221). The inhA gene was ampliﬁed using primer
inhA-for1 5¢-GTCACACCGACAAACGTCAC-3¢ (nucleotides
100–119) and inhA-rev1 5¢-TCGCTGTCGGTGACGTCA-3¢
(nucleotides 420–403).
The reaction was performed by using a two-round ampliﬁ-
cation on the thermal cycler PTC-200 (MJ Research, Inc.,
Waltham, MA, USA). The ﬂuorescently labelled PCR
products (8 lL) were resuspended in 10 lL of hybridization
buffer containing 0.01 lM tetramethyl-6-carboxyrhodamine-
labelled oligonucleotide as the target of the hybridization
positive control probe.
DNA hybridization assay
To prepare the hybridization sample, an equal volume of the
amplicon (6 lL) was removed from each PCR reaction and
the positive control reaction, respectively. To denature the
double-stranded DNA, the hybridization sample was heated
at 95C for 5 min followed by snap chilling on ice for 5 min.
The mixture was brieﬂy centrifuged. Then the above
hybridization sample was added with 9 lL of the hybridiza-
tion solution (7.5· SSC, 12.5· Denhart solution and 0.5%
SDS). The prepared hybridization samples (15 lL) were
applied to the individual reaction well on the glass slide.
Finally, the sealed cartridge was placed in a 55C oven incu-
bated for 2 h. When the hybridization was completed, the
slide was washed three times sequentially in the pre-warmed
(50C) washing solution A (2· SSC/0.2% SDS) for 5 min
followed by washing solution B (0.2· SSC) for 1 min.
Laser-induced ﬂuorescence scanning
The slides were scanned with a LuxScan-10K scanner (Capi-
talBio Corp.). The scanning conditions were: wavelength,
532 nm; laser power, 33%; pixel size, 10 · 10 lM; PMT volt-
age, 550 V. The mean of the ﬂuorescence signals for the
quintuple spots was calculated after subtraction of the ﬂuo-
rescence intensity of the negative control. To minimize the
effects of nonspeciﬁc hybridization and false positive, a
threshold ratio of signal-to-noise >3 was implemented, based
on the statistical analysis of the hybridization data obtained
from 200 negative control samples.
Target sequencing
PCR products were then puriﬁed using the PCR Product
Pre-sequencing kit (USB Corporation, Cleveland, OH, USA)
and sequenced using forward primer and the BigDye Termi-
nator (version 3.1) cycle sequencing kit in an ABI PRISM3100
genetic analyzer (Applied Biosystems, Foster City, CA, USA).
Results
rpoB mutations in clinical isolates
The panel of 70 M. tuberculosis isolates contained 50 MDR-
TB isolates and 20 isolates sensitive to both RIF and INH;
the MDR-TB isolates included 30 RIF-resistant isolates and
50 INH-resistant isolates.
TABLE 1. Immobilized oligonucle-
otides for tuberculosis hybridiza-
tion analysis
Oligonucleotide
Amino acid
position
Nucleotide
substitution Sequence 5¢ ﬁ 3¢
511 rpoB 511 CTG ﬁ CCG 5¢-NH2-TTGGCTCGGCTGG-3¢
513 rpoB 513 CAA ﬁ AAA 5¢-NH2-CTGAGCAAATTCATGG-3¢
513 rpoB 513 CAA ﬁ CCA 5¢-NH2-CTGAGCCCATTCATGG-3¢
533 rpoB 533 CTG ﬁ CCG 5¢-NH2-GCCCCGGCGCCGACA-3¢
531 rpoB 531 TCG ﬁ TTG 5¢-NH2-CCGACTGTTGGCG-3¢
531 rpoB 531 TCG ﬁ TGG 5¢-NH2-CGACTGTGGGCGC-3¢
526 rpoB 526 CAC ﬁ TAC 5¢-NH2-GTTGACCTACAAGCGC-3¢
526 rpoB 526 CAC ﬁ GAC 5¢-NH2-GTTGACCGACAAGCG-3¢
526 rpoB 526 CAC ﬁ CTC 5¢-NH2-GTTGACCCTCAAGCGC-3¢
526 rpoB 526 CAC ﬁ CGC 5¢-NH2-GTTGACCCGCAAGCG-3¢
516 rpoB 516 GAC ﬁ GTC 5¢-NH2-TCATGGTCCAGAACAAC-3¢
516 rpoB 516 GAC ﬁ TAC 5¢-NH2-TTCATGTACCAGAACAAC-3¢
516 rpoB 516 GAC ﬁ GGC 5¢-NH2-GTTCTGGCCCATGAA-3¢
315 katG 315 AGC ﬁ ACC 5¢-NH2-GCGATCACCACCGGCATCGAG-3¢
315 katG 315 AGC ﬁ AAC 5¢-NH2-GCGATCAACACCGGCATCGAG-3¢
)15 inhA -15 C ﬁ T 5¢-NH2-GGCGAGATGATAGGTTGTCGG-3¢
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Analysis of MDR-TB isolates showed that rifampin-resistant
strains 100% had rpoB gene mutations. The most frequently
encountered mutations were at codon 531, followed by 513,
with a frequency of 73% and 27%, respectively (Table 2).
Analysis of the codons showed two different mutations at
codon 531 and one mutation at codon 513. Mutation 531
TCG>TTG (Ser>Leu) occurred in 20 isolates (66.7%),
whereas mutation 531 TCG>TGG (Ser>Trp) occurred in
two isolates (6.7%). The rpoB codon 513 was affected by the
mutation of CAA>CCA (Gln>Pro) in eight isolates. Mutations
in codons 511, 516, 526, and 533 were not seen. Part of
hybridization pattern of rifampin-resistant isolates was shown
in Fig. 2. Of the 30 rifampin-resistant isolates, all were cor-
rectly identiﬁed by the specialized microarray. Mutation
detection results showed that none of the RIF-susceptible iso-
lates had mutations in the core region of rpoB gene.
katG and inhA mutations in clinical isolates
The katG315 and inhA-15 genotypes of the 50 isolates were
determined.
katG315: Forty-one (82%) isolates were found to have
katG315 mutation (32 were AGC>ACC, nine were
AGC>AAC).
inhA-15: Nine (18%) isolate showed an inhA-15 (C>T)
mutation.
None of the INH-resistant isolates had more than one of
the target mutations in katG or inhA gene. Furthermore, a
combination of two single-point mutations in rpoB and katG
gene was observed in 30 MTD-TB strains.
Sequencing of the isolates
The results of the microarray and sequencing were in com-
plete agreement, with no exceptions. No mutations were
detected in any INH-susceptible isolates. The results of
DNA sequencing showed that all of the 20 RIF-susceptible
isolates had wild-type rpoB. Of the 30 RIF-resistant isolates,
all were found to have rpoB mutations, with the majority at
codon 531.
Discussion
The most frequent position of rpoB mutation reported in
China was Ser-531, which was similar to that reported from
Japan and Korea [15]. Over 80% of INH-resistant isolates
have been reported to harbour at least one of the two most
common mutations: AGC>ACC at codon 315 in katG or a
C>T substitution at )15 at the inhA locus [5,16]. Compared
to DNA sequencing, microarray has been conﬁrmed to be a
simple, reliable and cost-effective method with high sensitiv-
ity and speciﬁcity, and has already been applied for the
detection of rpoB and gyrA gene mutations for the prediction
of rifampin and ﬂuoroquinolone resistance in TB [17].
This is the ﬁrst report of the use of microarray for RIF
and INH resistance gene mutation analysis using a large ser-
ies of clinical samples in Chongqing. In the present study,
mutations with particular katG315 Ser were detected in 82%
of INH-resistant isolates. By contrast, mutations in the inhA
regulatory region are less common, and are seen in 18% of
INH-resistant strains. Other studies have demonstrated
TABLE 2. Distribution of the rpoB, katG and inhA mutations
in tuberculosis clinical isolates
Mutated
codon
Nucleotide
change
Number
of samples
rpoB 531 TCG ﬁ TTG 20
rpoB 531 TCG ﬁ TGG 2
rpoB 513 CAA ﬁ CCA 8
katG315 AGC ﬁ ACC 32
katG315 AGC ﬁ AAC 9
inhA-15 C ﬁ T 9
(a) (b)
FIG. 2. Examples of DNA microarray
hybridization pattern for H37Rv ATCC
27294 and rpoB531 Mct. (a) Representa-
tive hybridizations with reference strain.
(b) Representative hybridizations with
TB clinical isolate rpoB531 Mct.
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mutations in other genes potentially affecting the susceptibil-
ity to INH, such as ahpC, oxyR and kasA [15], that were not
targeted in our assays. In the present study, the results of
microarray are completely consistent with those of DNA
sequencing. All of the RIF resistant and INH resistant isolates
were found to be resistant, giving 100% sensitivity. Of the
total 50 INH resistant isolates, 41 of them had katG315
mutation and nine of them had inhA mutation, and all of
them were correctly identiﬁed by the assay, achieving 100%
speciﬁcity. All of RIF-resistant clinical isolates revealed rpoB
mutation. In all of the susceptible clinical isolates, no muta-
tion was found. The results of the microarray have a speci-
ﬁcity and sensitivity higher than by other method. We
deduced that the main reason was the small numbers tested
and the need for more drug-resistant isolates to be tested in
the additional study. The other obvious reason might be that
the most frequent drug-resistance mutations in Chongqing
were rpoB531, rpoB513 and katG315, which were all
designed for detection in the microarray. Thus, the micro-
array was particularly well suited for testing the drug-resis-
tant phenotypes of TB isolates in Chongqing. The microarray
described was capable of detecting 13 of the 36 different
mutations in the RRDR of rpoB, two of three different muta-
tions at katG315 and one of one at inhA-15. The major limi-
tation of this microarray is that it does not cover all
mutations, or all species/strains. However, the lower cost of
the microarray made it suitable for the detection of drug-
resistance TB in the developing countries (e.g. China). Fur-
ther investigation of these isolates is needed to identify
whether the addition of one or more targets in other genes
would increase the sensitivity of the assays.
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